Black Horehound

Black Horehound (Ballota nigra) contains active compounds such as marrubiin, acteoside, and flavonoids. Its mechanism of action involves antispasmodic effects on the gastrointestinal tract and sedative actions on the nervous system. These properties help relax stomach muscles and calm the nerves associated with nausea and motion sickness. Evidence Level B supports these traditional applications, suggesting the terpene ketones contribute to the herb's nervine qualities.

Black Horehound may interact with sedative medications, potentially increasing drowsiness due to its nervine properties. Because it may affect thyroid function, it could interfere with thyroid hormone replacement therapies. Individuals taking CNS depressants or thyroid medications should exercise caution. While specific clinical interaction studies are limited (Evidence Level B), the theoretical risk warrants medical consultation before combining with prescription drugs.

The standard adult dosage for Black Horehound is 2-4ml of liquid tincture or 2g of dried herb as a tea, taken three times daily. This recommendation is based on traditional European medicine standards (Evidence Level B). Users should adhere to these guidelines to minimize the risk of gastrointestinal upset or excessive sedation. Always follow product-specific instructions if available.

Black Horehound is considered unsafe during pregnancy. Traditional evidence and pharmacological data suggest it may stimulate uterine contractions or disrupt hormonal balance. Furthermore, potential side effects like gastrointestinal distress and thyroid interference pose significant risks to fetal development. Women who are pregnant or breastfeeding should strictly avoid this herb. Healthcare providers recommend seeking safer alternatives for nausea relief during pregnancy.

Reported side effects of Black Horehound include gastrointestinal upset and sedation. The herb may also affect thyroid function, making it contraindicated for individuals with pre-existing thyroid conditions. Its characteristic unpleasant smell is often noted. Due to these potential adverse reactions, users should monitor their response carefully. Evidence Level B indicates these risks are based on pharmacological understanding and traditional use data.